BRD4 and cancer: These demonstrated features of CAP not only make it a potential onco-therapeutic strategy but also an excellent remedy to prevent cancer cells from becoming resistant to HDAC inhibitors, rendering the joint use of HDAC inhibitors and CAP a novel and promising combinatorial strategy for cancer treatment.